Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Biofabrication
|
February 9, 2021
An interfacial self-assembling bioink for the manufacturing of capillary-like structures with tuneable and anisotropic permeability
Yuanhao Wu, Gabriele Maria Fortunato, Babatunde O Okesola, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2019
Exposure time versus cytotoxicity for anticancer agents
David M Evans, Jianwen Fang, Thomas Silvers, et al.
Plos One
|
May 19, 2016
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
Deepti Saxena, Michael Spino, Fernando Tricta, et al.
Journal of the National Cancer Institute
|
June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
Eric Polley, Mark Kunkel, David Evans, et al.
Lancet (London, England)
|
May 21, 2017
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
Jeffrey S Heier, Saleema Kherani, Shilpa Desai, et al.
Oncotarget
|
October 22, 2021
ATR inhibition reverses the resistance of homologous recombination deficient MGMT<sup>low</sup>/MMR<sup>proficient</sup> cancer cells to temozolomide
Lara H El Touny, Curtis Hose, John Connelly, et al.
Journal of Neurochemistry
|
August 26, 2015
Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone
Liangliang Zhao, Majda Hadziahmetovic, Chenguang Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2009
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]
Andrew G Jobson, George T Lountos, Philip L Lorenzi, et al.
Nature
|
June 12, 2024
Strand-resolved mutagenicity of DNA damage and repair
Craig J Anderson, Lana Talmane, Juliet Luft, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics
Amy Steadman, Alfred Andama, Alexey Ball, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Biofabrication
|
February 9, 2021
An interfacial self-assembling bioink for the manufacturing of capillary-like structures with tuneable and anisotropic permeability
Yuanhao Wu, Gabriele Maria Fortunato, Babatunde O Okesola, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2019
Exposure time versus cytotoxicity for anticancer agents
David M Evans, Jianwen Fang, Thomas Silvers, et al.
Plos One
|
May 19, 2016
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
Deepti Saxena, Michael Spino, Fernando Tricta, et al.
Journal of the National Cancer Institute
|
June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
Eric Polley, Mark Kunkel, David Evans, et al.
Lancet (London, England)
|
May 21, 2017
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
Jeffrey S Heier, Saleema Kherani, Shilpa Desai, et al.
Oncotarget
|
October 22, 2021
ATR inhibition reverses the resistance of homologous recombination deficient MGMT<sup>low</sup>/MMR<sup>proficient</sup> cancer cells to temozolomide
Lara H El Touny, Curtis Hose, John Connelly, et al.
Journal of Neurochemistry
|
August 26, 2015
Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone
Liangliang Zhao, Majda Hadziahmetovic, Chenguang Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 11, 2009
Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide]
Andrew G Jobson, George T Lountos, Philip L Lorenzi, et al.
Nature
|
June 12, 2024
Strand-resolved mutagenicity of DNA damage and repair
Craig J Anderson, Lana Talmane, Juliet Luft, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 30, 2023
New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics
Amy Steadman, Alfred Andama, Alexey Ball, et al.
Page
of 5